Experimental Pathology Laboratories Acquires Aclairo Pharmaceutical Development Group

On January 13, 2016, Experimental Pathology Laboratories acquired business services company Aclairo Pharmaceutical Development Group

This is Experimental Pathology Laboratories’ 1st transaction in the Business Services sector.
This is Experimental Pathology Laboratories’ 1st transaction in the United States.
This is Experimental Pathology Laboratories’ 1st transaction in Virginia.

M&A Deal Summary
Date	2016-01-13
Target	Aclairo Pharmaceutical Development Group
Sector	Business Services
Buyer(s)	Experimental Pathology Laboratories
Deal Type	Add-on Acquisition

Vienna, Virginia, United States

Aclairo Pharmaceutical Development Group, Inc. is an independent and objective nonclinical and regulatory advice to the pharmaceutical industry.

SEARCH BY

Sterling, Virginia, United States

Category	Company
Sector	Life Science

Experimental Pathology Laboratories, Inc. (EPL, Inc.) is an independent provider of GLP-compliant toxicologic pathology services.

DEAL STATS	#
Overall	1 of 1
Sector: Business Services M&A	1 of 1
Type: Add-on Acquisition M&A Deals	1 of 1
State: Virginia M&A	1 of 1
Country: United States M&A	1 of 1
Year: 2016 M&A	1 of 1